Between July 7, 2023, and June 30, 2024, Houston-based University of Texas MD Anderson had the lowest rate of Clostridioides difficile infections among cancer hospitals exempt from reporting to Medicare’s Inpatient Prospective Payment System.
Eleven PPS-exempt cancer hospitals are required to participate in the PPS-Exempt Cancer Hospital Quality Reporting Program, a specialized quality reporting program established in 2010 by the ACA.
Healthcare associated infections are measured by a standard infection ratio, which compares the observed number of infections to the number of predicted infections.
All 11 PPS-exempt cancer hospitals reported C. diff infection rates under the national C. diff infection rate.
Here are the C. diff infection rates of PPS-exempt cancer hospitals between July 7, 2023, and June 30, 2024, according to CMS data:
- University of Texas MD Anderson Cancer Center (Houston): 0.237
- University of Miami Sylvester Comprehensive Cancer Center: 0.38
- Moffitt Cancer Center (Tampa, Fla.): 0.382
- Memorial Sloan Kettering Cancer Center (New York City): 0.437
- The James Cancer Hospital and Solove Research Institute (Columbus, Ohio): 0.453
- Fox Chase Cancer Center (Philadelphia): 0.598
- Roswell Park Cancer Institute (Buffalo, N.Y.): 0.694
- Dana-Farber Cancer Institute (Boston): 0.711
- USC Kenneth Norris Jr. Cancer Hospital (Los Angeles): 0.796
- Fred Hutchinson Cancer Institute (Seattle): 0.874
- City of Hope (Duarte, Calif.): 0.877
